Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis.

Hu K, He X, Yu F, Yuan X, Hu W, Liu C, Zhao F, Dou J.

Immunol Invest. 2011;40(3):265-78. doi: 10.3109/08820139.2010.534219. Epub 2011 Jan 4.

PMID:
21204603
2.

An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.

Hu K, Dou J, Yu F, He X, Yuan X, Wang Y, Liu C, Gu N.

Vaccine. 2011 Feb 4;29(7):1455-62. doi: 10.1016/j.vaccine.2010.12.031. Epub 2010 Dec 24.

PMID:
21185849
3.

Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.

Inoue T, Inoue Y, Nakamura T, Yoshida A, Takahashi K, Inoue Y, Shimomura Y, Tano Y, Fujisawa Y, Aono A, Hayashi K.

Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4209-15.

PMID:
11095617
4.

[Enhancement of herpes simplex virus-1 glycoprotein-D DNA vaccine induced specific immune responses by coimmunization with interleukin-2 genetic adjuvant].

Liu XJ, Zhu MZ, Song GX, Xu YF, Liu HW, Wang S, Yang BL, Dong FT, Xu XM.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Feb;27(1):67-72. Chinese.

PMID:
15782496
5.

The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis.

Inoue T, Inoue Y, Nakamura T, Yoshida A, Inoue Y, Tano Y, Shimomura Y, Fujisawa Y, Aono A, Hayashi K.

Jpn J Ophthalmol. 2002 Jul-Aug;46(4):370-76.

PMID:
12225814
6.

IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.

Sin JI, Kim JJ, Arnold RL, Shroff KE, McCallus D, Pachuk C, McElhiney SP, Wolf MW, Pompa-de Bruin SJ, Higgins TJ, Ciccarelli RB, Weiner DB.

J Immunol. 1999 Mar 1;162(5):2912-21.

7.

Topical Administration Is a Promising Inoculating Route versus Intramuscular Inoculation for the Nanoparticle-Carried DNA Vaccine to Prevent Corneal Infections.

Hu K, Malla T, Zhai Y, Dong L, Tang R.

Ophthalmic Res. 2015;55(2):99-110. doi: 10.1159/000441898. Epub 2015 Dec 10.

PMID:
26650397
9.
10.
11.

Immunization with dendritic cell-based DNA vaccine pRSC-NLDC145.gD-IL21 protects mice against herpes simplex virus keratitis.

Tang R, Zhai Y, Dong L, Malla T, Hu K.

Immunotherapy. 2018 Mar;10(3):189-200. doi: 10.2217/imt-2017-0060.

PMID:
29370719
12.

Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.

Bettahi I, Nesburn AB, Yoon S, Zhang X, Mohebbi A, Sue V, Vanderberg A, Wechsler SL, BenMohamed L.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4643-53.

PMID:
17898288
13.
14.
16.

Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.

Cui FD, Asada H, Kishida T, Itokawa Y, Nakaya T, Ueda Y, Yamagishi H, Gojo S, Kita M, Imanishi J, Mazda O.

Gene Ther. 2003 Dec;10(25):2059-66.

PMID:
14595378
17.

Effect of herpes simplex virus-1 gD or gD-IL-2 DNA vaccine on herpetic keratitis.

Inoue T, Inoue Y, Hayashi K, Shimomura Y, Fujisawa Y, Aono A, Tano Y.

Cornea. 2002 Oct;21(7 Suppl):S79-85.

PMID:
12484704
18.

Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.

Cui FD, Asada H, Jin ML, Kishida T, Shin-Ya M, Nakaya T, Kita M, Ishii M, Iwai M, Okanoue T, Imanishi J, Mazda O.

Gene Ther. 2005 Jan;12(2):160-8.

PMID:
15470476
19.
20.

Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses.

Higgins TJ, Herold KM, Arnold RL, McElhiney SP, Shroff KE, Pachuk CJ.

J Infect Dis. 2000 Nov;182(5):1311-20. Epub 2000 Oct 9.

PMID:
11023455

Supplemental Content

Support Center